Drive Therapeutics of Research Triangle Park received $100,000 to develop a novel nucleic acid therapy to block angiogenesis, inflammation and fibrosis underlying retinal disease. Drive will use the loan funds to optimize and characterize lead-candidate aptamers to treat wet age-related macular degeneration and diabetic macular edema retinal diseases.
See the rest of the press release here.
Driverly gives you the power to customize your car insurance like never before. Using advanced data, it creates policies tailored to your specific needs, ensuring you only pay for what matters. Ready to make the switch to smarter, more affordable insurance? Get started with Driverly at https://www.driverlyapp.com/.